NIOX Group (LON:NIOX) Issues Quarterly Earnings Results

NIOX Group (LON:NIOX) posted its earnings results on Wednesday. The company reported GBX 1.41 EPS for the quarter, Digital Look Earnings reports. NIOX Group had a return on equity of 10.01% and a net margin of 14.74%.

NIOX Group Stock Performance

Shares of NIOX traded up GBX 0.80 during trading hours on Friday, reaching GBX 66.80. 175,685 shares of the company’s stock traded hands, compared to its average volume of 796,137. The firm has a market capitalization of £281.14 million, a price-to-earnings ratio of 40.73 and a beta of 0.92. The company has a debt-to-equity ratio of 1.06, a current ratio of 4.60 and a quick ratio of 1.94. NIOX Group has a twelve month low of GBX 53.84 and a twelve month high of GBX 76. The business’s fifty day simple moving average is GBX 65.75 and its two-hundred day simple moving average is GBX 61.67.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.